Fig. 1From: Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safetyConsolidated Standards of Reporting Trials (CONSORT) flow-chart diagram of the study. Abbreviations: 0.1% loading dose, group receiving 0.1% for the first six months followed by 0.01% for 18 months; 0.01%, group receiving 0.01% for 24 months; N, NumberBack to article page